Trials / Completed
CompletedNCT00855179
Assess the Efficacy and Tolerability of Antistax Film-coated Tablets in Patients With Chronic Venous Insufficiency
A 12-week, Double-blind, Randomised, Placebo-controlled, Multicentre Trial to Evaluate Efficacy and Tolerability of Antistax® Film Coated Tablets, 720 mg/Day Orally, in Male and Female Patients Suffering From Chronic Venous Insufficiency
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 250 (actual)
- Sponsor
- Boehringer Ingelheim · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To assess the efficacy and tolerability of Antistax film coated tablets in patients with chronic venous insufficiency (CVI, CEAP Classification: Clinical class 3 and 4a).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Red vine leaf extract (AS 195) | Antistax film-coated tablet 360 mg |
| DRUG | Placebo | Placebo tablets identical to those containing Anstistax 360 mg |
Timeline
- Start date
- 2009-03-01
- Primary completion
- 2009-11-01
- First posted
- 2009-03-04
- Last updated
- 2014-05-16
Locations
20 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT00855179. Inclusion in this directory is not an endorsement.